Vail Resorts Posts Downbeat Q3 Results, Joins Concrete Pumping, DocuSign And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Vail Resorts Posts Downbeat Q3 Results, Joins Concrete Pumping, DocuSign And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 0.1% on Friday.
美股期貨今天早間略微走高，道瓊斯指數期貨收漲約0.1％。
Shares of Vail Resorts, Inc. (NYSE:MTN) fell sharply in today's pre-market trading after the company reported weaker-than-expected results for its third quarter.
在企業公佈第三季度業績低於預期後，vail resorts股票（NYSE:MTN）在今日美股盤前交易中大幅下跌。
The company posted quarterly earnings of $9.54 per share, missing market estimates of $10.03 per share. The company's sales came in at $1.28 billion versus expectations of $1.30 billion, according to data from Benzinga Pro.
根據Benzinga Pro的數據，該公司每股季度收益爲9.54美元，低於市場預期的每股10.03美元。該公司的銷售額爲12.8億美元，低於市場預期的13億美元。
Vail Resorts shares declined 6.8% to $180.77 in pre-market trading.
vail resorts的股票在美股盤前交易中下跌了6.8％，跌至每股180.77美元。
Here are some big stocks recording losses in today's pre-market trading session.
以下是在今天美股盤前交易中錄得下跌的一些大型股票。
- Biomea Fusion, Inc. (NASDAQ:BMEA) shares tumbled 59.2% to $4.60 in pre-market trading after the company received notice from the FDA that Its trials of BMF-219 have been placed on clinical hold.
- Latam Logistic Properties, S.A. (NYSE:LPA) shares fell 16% to $39.60 in pre-market trading after jumping 49% on Thursday.
- Concrete Pumping Holdings, Inc. (NASDAQ:BBCP) shares dipped 13% to $6.55 in pre-market trading after posting weaker-than-expected second-quarter results.
- FibroBiologics, Inc. (NASDAQ:FBLG) shares fell 8.1% to $9.48 in pre-market trading. FibroBiologics shares jumped around 54% on Thursday after the company in a FormRW disclosed that its Registration Statement has not been declared effective by the SEC and no securities have been issued or sold under the Registration Statement.
- Eastern Bankshares, Inc. (NASDAQ:EBC) shares fell 7.7% to $12.25 in pre-market trading.
- DocuSign, Inc. (NASDAQ:DOCU) shares declined 7.1% to $50.70 in pre-market trading. DocuSign reported better-than-expected earnings for its first quarter and the company's board also authorized a $1 billion increase to its existing stock repurchase program. The company said it sees second-quarter billings in the range of $715 million to $725 million.
- Samsara Inc. (NYSE:IOT) shares declined 6.2% to $32.69 in pre-market trading after the company reported first-quarter earnings.
- Fitell Corporation (NASDAQ:FTEL) shares fell 5.3% to $15.14 in pre-market trading.
- Replimune Group, Inc. (NASDAQ:REPL) shares fell 5.2% to $6.74 in pre-market trading. Replimune Group shares jumped around 28% on Thursday after the company announced the topline results from the primary analysis of the IGNYTE clinical trial of RP1 plus nivolumab in anti-PD1 failed melanoma.
- Biomea Fusion公司（NASDAQ:BMEA）的股票在美股盤前交易中暴跌59.2％，此前該公司收到FDA通知，其BMF-219的臨床試驗已被暫停。
- Latam Logistic Properties股票（NYSE:LPA）在週四大漲49％後，今日美股盤前交易中下跌了16％。
- Concrete Pumping Holdings股票（NASDAQ:BBCP）在發佈低於預期的第二季度業績後，今日美股盤前交易中下跌了13％。
- FibroBiologics股票（NASDAQ:FBLG）在公司披露申報文件未獲SEC批准並未進行證券發行後，今日美股盤前交易中下跌了8.1%。FibroBiologics股票在週四大漲約54％。
- Eastern Bankshares股票（NASDAQ:EBC）在今日美股盤前交易中下跌了7.7％，跌至每股12.25美元。
- DocuSign股票（NASDAQ:DOCU）在企業公佈第一季度業績高於預期並表示董事會已授權該公司現有股票回購計劃增加10億美元后，今日美股盤前交易中下跌了7.1%。該公司表示預計第二季度的訂單額將在7.15億美元至7.25億美元之間。
- Samsara Inc.股票（NYSE:物聯網）在企業公佈第一季度業績後，在美股盤前交易中下跌了6.2%。
- Fitell Corporation股票（NASDAQ:FTEL）在今日美股盤前交易中下跌了5.3%，跌至每股15.14美元。
- Replimune Group股票（NASDAQ:REPL）在發佈RP1 plus Nivolumab在抗PD1失敗性黑色素瘤中的IGNYTE臨床試驗的主要分析結果後，今日美股盤前交易中下跌了5.2％。在週四，Replimune Group的股票大漲約28％。
Now Read This: Fear & Greed Index In 'Neutral' Zone Ahead Of Jobs Report; Dow Settles Higher
現在請閱讀這個：恐懼與貪婪指數處於“中立”區域， 就業報告發布前；道瓊斯指數收漲
Don't forget to check out our premarket coverage here
別忘了查看我們的盤前報道。
譯文內容由第三人軟體翻譯。